SCHEMBL24822268

SCHEMBL24822268

CCn1nc(Oc2c(Cl)cc(-n3c(C)ccc3C)cc2Cl)ccc1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 2/20 0.40
▸ BRD9 Q9H8M2 3/20 0.39
▸ ALDH1A1 P00352 1/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ MYC P01106 1/20 0.35
▸ NR4A1 P22736 1/20 0.35
▸ GAA P10253 1/20 0.33
▸ THRA P10827 7/20 0.33
▸ THRB P10828 7/20 0.33
▸ GRM5 P41594 1/20 0.33
▸ CYP2C9 P11712 2/20 0.32
▸ UGT1A1 P22309 1/20 0.32
▸ ABCG2 Q9UNQ0 1/20 0.32
▸ SLCO1B1 Q9Y6L6 1/20 0.32
▸ CTSB P07858 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29821560 0.87 NR4A1 (0.40) PTGS2ALDH1A1LMNAMYCNR4A1
SCHEMBL23168839 0.86 TSHR (0.50) ALDH1A1CYP2C19GAACYP2C9TSHR
SCHEMBL24822266 0.82 PTGS2 (0.40) PTGS2BRD9ALDH1A1CYP2C19LMNA
SCHEMBL24820995 0.81 MYC (0.35) MYCNR4A1THRATHRBGRM5
SCHEMBL24819268 0.80 KMT2A (0.46) ALDH1A1CYP2C19CYP1A2CYP2C9CYP3A4
SCHEMBL24821004 0.79 DPP4 (0.34) ALDH1A1MYCNR4A1GAACTSB
SCHEMBL23168671 0.78 LMNA (0.41) PTGS2ALDH1A1LMNA
SCHEMBL23168781 0.75 FAAH (0.40) MYCNR4A1THRATHRBCYP2C9
SCHEMBL23168964 0.74 THRA (0.61) THRATHRBCYP2C9UGT1A1ABCG2
SCHEMBL23168666 0.73 KDM4E (0.50) ALDH1A1LMNAMYCNR4A1THRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220411400-A1 CHEMICAL COMPOUND AS THYROID HORMONE BETA RECEPTOR AGONIST AND USE THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2022-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411400-A1 CHEMICAL COMPOUND AS THYROID HORMONE BETA RECEPTOR AGONIST AND USE THEREOF THRB, TSHR, THRA PTGS2 1229/4885BRD9 861/4885ALDH1A1 1134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback